Conclusion: Cardiogenic shock complicating ACS portends very poor short and long-term survival with particularly high mortality in the non-STEMI and multivessel PCI subgroups. http://dx.
Background: With rising numbers and complexity of percutaneous coronary interventions being performed, the incidence of cardiac arrest in CCL is likely to increase. We undertook a series of multi-disciplinary simulation sessions to systematically define problematic areas, practice deficiencies and to propose solutions to improve cardiac arrest care in the CCL.
Methods: In 2018, ten simulation sessions were held at Western Health CCL to simulate different cardiac arrest scenarios. Participants included cardiologists, cardiology and anaesthetic registrars, intensive care registrars, nursing staff and CCL technicians. Post-simulation feedback was analysed qualitatively into common themes.
Results: Problematic areas and challenges encountered during a cardiac arrest scenario in CCL were identified and grouped into four areas of 1) equipment (e.g. CCL C-arm), 2) vascular access and drugs (e.g. standardising concentrations and venous access site), 3) physical environment (e.g. spatial limitations) and 4) resource management (e.g. leadership and role allocation). Proposed solutions included scheduling of regular simulation training for all health professionals who are likely to be involved in management of cardiac arrest in CCL; increasing familiarity with the unusual physical environment and equipment in CCL including automated cardio-pulmonary resuscitation devices and radiation-exposure safety awareness; and rapid formation of 2 team leaders to improve cardiac arrest care efficiency.
Conclusions: Cardiac arrest in CCL is a unique clinical event that differs from other emergency scenarios in hospitals. This necessitates specific training, which can be provided in a structured simulation program to improve technical and non-technical skills with potential to improve cardiac arrest care and clinical outcomes. Background: Cardiogenic shock (CS) complicates ∼5% of patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), with the highest mortality in certain subgroups despite contemporary ACS treatment.
Methods: Patients with ACS enrolled in the Melbourne Interventional Group registry (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) with CS (n = 636) were analysed according to pre-specified subgroups. Those with STEMI were compared to non-STEMI, and multivessel PCI compared to single-vessel PCI. Short-term MACE (death, MI, target-vessel revascularisation) and long-term National Death Index (NDI)-linked mortality were assessed between the subgroups.
Results: Patients with CS presented with high rates of STEMI (89%) and a preponderance of multivessel disease (70%), however, only 12% underwent multivessel PCI. Inhospital and 30-day MACE were high in the CS cohort (46% and 47% respectively). Long-term NDI-linked mortality was 51% in the entire CS cohort. Subgroup analyses revealed greater in-hospital, 30-day and NDI-linked mortality among those who presented with non-STEMI compared to those with STEMI (63% vs. 38%, 64% vs. 38%, and 79% vs. 47%, respectively, all p < 0.01). There was a trend towards higher in-hospital and 30-day mortality among those who underwent multivessel PCI (50% vs. 39%, p = 0.07 and 50% vs. 40%, p = 0.09). Higher long-term NDI-linked mortality was observed in the multivessel PCI subgroup (63% vs. 49%, p < 0.05).
